Related Experiment Videos
Metastatic ependymoma manifested by pancytopenia
S E Farrier1, S Agosti, M Morgan
1Department of Pathology, University of South Florida College of Medicine, Tampa.
Southern Medical Journal
|December 1, 1994
Summary
Metastatic ependymoma can cause myelophthisic anemia, a rare cause of pancytopenia. This case highlights the importance of considering metastatic ependymoma in patients with unexplained low blood counts after spinal cord tumor surgery.
Area of Science:
- Neuro-oncology
- Hematology
- Pathology
Background:
- Ependymoma is a primary tumor of the central nervous system.
- Surgical resection is a common treatment for ependymoma.
- Long-term surveillance for metastatic disease is crucial after treatment.
Observation:
- A 32-year-old man presented with pancytopenia.
- He had a history of thoracolumbar myeloresection for intramedullary ependymoma 12 years prior.
- Bone marrow examination showed extensive fibrosis and tumor infiltration.
Findings:
- The findings were compatible with metastatic ependymoma.
- This resulted in myelophthisic anemia, a condition where the bone marrow is crowded by tumor cells, impairing blood cell production.
- This is the first reported case of myelophthisic anemia secondary to metastatic ependymoma.
Implications:
- Metastatic ependymoma should be included in the differential diagnosis for pancytopenia in patients with a history of this spinal cord tumor.
- This case underscores the potential for late recurrence and metastasis of ependymoma.
- Further research into the metastatic potential and long-term outcomes of ependymoma is warranted.